IL6 and cystic fibrosis: In the CF cohort, mediators increased only slightly by 1.2–1.5 times (IL-6, IL-8, NE, TIMP-1, and MMP-9), attributable to their elevated baseline levels (Figure 2 and Supplementary Table S3).